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doi:10.1016/j.asjsur.2012.04.028Summary Head and neck arteriovenous malformations (AVMs), including lingual AVMs, are
unusual and rare. There are many treatment options including sclerotherapy, endovascular
or percutaneous embolization, and surgical excision. A combination of preoperative emboliza-
tion and surgical resection is commonly used for head and neck AVMs. However, in most cases,
surgical resection causes significant morbidity. Single-modality approaches such as transarter-
ial embolization are sometimes performed. Herein, we used the copolymer Onyx (ethylenee
vinyl alcohol copolymer) as an embolizing agent and obtained satisfactory therapeutic
outcomes. To our knowledge, this is the first report of lingual AVMs treated using Onyx embo-
lization.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Despite the low prevalence of head and neck arteriovenous
malformations (AVMs), resection of particularly large
lingual AVMs may impair lingual functions. We report the
case of a patient with a large lingual AVM. The patient was
treated by a novel, previously unreported embolization
approach, using the copolymer Onyx. Onyx is a liquidof Diagnostic Radiology, Shin
umber 95, Wenchang Road,
11160, ROC.
.com.tw (H.-F. Wong).
n Surgical Association. Publishedembolizing agent, use of which has become increasingly
common in past two decades. Compared with other liquid
embolizing agents, including absolute ethanol and n-BCA,
Onyx allows better implementation of focal embolization
and less ensuing inflammatory response.1 Using Onyx,
complete occlusion was successfully achieved, and no
severe complications ensued.
2. Case report
We report the case of a 42-year-old man who mainly com-
plained of a hemorrhagic lingual mass. He had noticed the
lingual mass 4e5 years ago. In April 2009, a fish bone hadby Elsevier Taiwan LLC. All rights reserved.
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rhage. Subsequently, his tongue was sutured at Taipei
Hospital. However, his lingual mass ruptured again 3 days
later when he arrived at our hospital for treatment.
Oropharyngeal examination, computed tomography (CT)
scanning, and angiography were performed.3. Results
On oropharyngeal examination, a 1.5 1.5-cm mass on the
dorsal surface of his tonguewas noted. Themass extended as
a bluish, tubular structure to the ventral portion of the
tongue. Subsequent CT examinations revealed a large mass
of 1.9 1.8 cm in the lingual apex extending ventrodorsally,
showing a large vascular sac with prominent venous drainage
(Fig. 1). Angiography via external carotid artery demon-
strated a disorganized, high-flow vascular nidus with an
engorged sac supplied by bilateral lingual arteries and
a prominent venous drainage at lingual apex (Fig. 2). CT and
angiography results established the diagnosis of lingual AVM.
The man was generally healthy otherwise.
Considering difficulties of resecting such a large lesion,
transarterial embolization was indicated. Therefore, after
obtaining informed consent from the patient and his family,
an ultraselectivemicrocatheterization approachwas used to
apply a copolymer of ethyleneevinyl alcohol (Onyx) through
bilateral lingual arteries to devascularize the AVM (Fig. 3).
Under general anesthesia, percutaneous access was ob-
tained via the right femoral artery. A 6F guiding catheter
(Cordis Envoy; Johnson and Johnson Medical, Miami, FL,
USA) was positioned in the proximal external carotid artery,
proximal to the lingual artery orifice. Next, a flow-directed
microcatheter (Marathon, ev3 Neurovascular) was navigated
into the lingual arteries as close as possible to the nidus of
AVM, with an aid of a 0.008-in. guidewire (Mirage, ev3
Neurovascular). Then, Onyx was slowly and progressively
injected into the nidus under continuous visual control using
biplane subtracted fluoroscopy. Total procedure time was
about 1 hour, and 3 cm3 (1.5 cm3/vial) Onyx was used.Figure 1 Enhanced computed tomography (CT) scanning
shows an engorged, vascularizedmass extending ventrodorsally.After Onyx embolization, no complication except lingual
pain was noted. The patient’s condition improved within 3
days. A follow-up CT 1 month later showed retention of the
copolymer within the vascular lesion. The prominent
venous drainage had resolved.4. Discussion
Mulliken and Glowacki initially classified vascular anomalies
into vascular tumors (e.g., the paradigmatic infantile
hemangiomas) and non-tumorous vascular malformations.2
These lesions are also subdivided into slow-flow (e.g.,
capillary, venous, and lymphatic malformations) and fast-
flow vascular malformations (e.g., AVMs).3 These classifi-
cations apply also to head and neck vascular malforma-
tions, which may occur due to rare errors in vascular
morphogenesis,1 affecting various sites.4 The most common
head-and-neck AVMs include buccal (31%), followed by
aural (16%) and nasal (11%) AVMs, whereas mandibular (5%)
or maxillary (4%) AVMs are less common.1 Focal lingual AVMs
are extremely rare.4
Low prevalence of lingual AVMs has prevented system-
atic studies to establish standard treatment protocols.5
Generally, various therapeutic strategies, including
surgical resection, endovascular embolization, stereotactic
radiosurgery, or percutaneous sclerotherapy,3 have been
used to treat symptomatic AVMs.
Of the treatment approaches discussed above, success
of endovascular AVM treatments is not well documented.
Some authors have reported endovascular approaches only
to supplement surgery for definitive treatment outcomes.5
Other groups have reported successful application of
embolization alone, but these studies have been limited to
smaller AVMs with no long-term follow-up.1,6 Nevertheless,
embolization of external carotid-artery AVMs has been
indicated in the following cases: (1) AVMs are deemed
surgically inoperable; (2) AVM clinical manifestations are
minimal; (3) surgery may likely cause significant morbidity;
or (4) the patient is unwilling or unfit to undergo surgery.7
Embolization-only treatments use soluble agents
capable of permeating a targeted AVM. These agents
include absolute ethanol, n-BCA, and Onyx.1,8 In 1990, Onyx
was first reported as an embolizing agent for cerebral
AVMs.8 Onyx is a liquid embolizing agent. Upon contacting
blood, Onyx congeals on the surface while maintaining
a liquid core, allowing the formation of a nonadhesive,
lava-like, contiguous mass.1 This property allows better
implementation of focal embolization, ensuring successful
and facile treatment. Onyx elicits less inflammatory
response and causes less endothelial damage or necrosis
than other agents such as n-BCA or absolute ethanol.1
Because of the large size of AVM in this case, we choose
Onyx for embolization, which provides better penetration
into the lesion, that a high successful rate of total occlusion
would be achieved.
Despite these advantages, Onyx is black and may cause
unsightly discolorations of superficial lesions such as dermal
lesions.1 Catheter entrapment is another potential compli-
cation, which has been reported in intracranial or extracra-
nial AVM treatments. Currently, Onyx has been mainly
applied to the cerebral or, to some extent, the peripheral
Figure 2 (A) Right external-carotid angiogram, anteroposterior (AP) view and (B) left external-carotid angiogram, oblique view
showing a disorganized, high-flow vascular nidus with an engorged vascular sac and prominent venous drainage at lingual apex
supplied by bilateral lingual arteries.
Embolization of lingual AVMs 161AVMs, including limb and visceral AVMs.5 Surprisingly, use of
Onyx for lingual AVMs has not been recorded so far. Here, we
present the case of a lingual, high-flow AVM in an adult who
was treated solely with endovascular Onyx embolization. InFigure 3 Bilateral external-carotid angiogram obtained immedia
lesion and (C, D) retention of the Onyx copolymer in the vascularthis case, our patient tolerated Onyx treatment without any
significant complication.
In conclusion, the best strategy for treating head-and-
neck AVMs should be based on personalized medicine.tely after embolization shows (A, B) devascularization of the
nidus and engorged vascular sac.
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endovascular or percutaneous application of embolizing
agents, surgery, or a combination of these modalities.
Treatment approaches should be based on the clinical and
angiographic outcomes as well as economic cost. Herein,
we report a case of a lingual arteriovenous malformation
with the Onyx embolization. Onyx is a more controllable
embolized agent compared with other options such as n-
NBCA and ethanol. This advantage provides a high
successful rate of total occlusion of the lesion, less proce-
dure time, less target vessels, and potentially less tissue
damage. Moreover, Onyx embolization could be an alter-
native choice for head and neck AVMs.References
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